These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3735303)

  • 21. Cellular pharmacology of N1- and N8-aziridinyl analogues of spermidine.
    Yuan ZM; Egorin MJ; Rosen DM; Simon MA; Callery PS
    Cancer Res; 1994 Feb; 54(3):742-8. PubMed ID: 8306336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative structure-activity relationships in 2,5-bis(1-aziridinyl)-p-benzoquinone derivatives against leukemia L-1210.
    Yoshimoto M; Miyazawa H; Nakao H; Shinkai K; Arakawa M
    J Med Chem; 1979 May; 22(5):491-6. PubMed ID: 458799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytostatic activity of inorganic heterocycles in an in vitro screening system.
    Lamberts HB; van der Meer-Kalverkamp A; van de Grampel JC; van der Huizen AA; Jekel AP; Mulder NH
    Oncology; 1983; 40(4):301-4. PubMed ID: 6866426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
    Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF
    Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992
    [No Abstract]   [Full Text] [Related]  

  • 25. Antitumor activity of metabolites of 1-hexylcarbamoyl-5-fluorouracil and related compounds against L1210 leukemia in vivo and L5178Y lymphoma cells in vitro.
    Hoshi A; Yoshida M; Inomata M; Iigo M; Ando N; Kuretani K
    J Pharmacobiodyn; 1980 Sep; 3(9):478-81. PubMed ID: 7463306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity correlations of anticancer agents: diaminopyrimidines, N-acyltriamines, bis-(1-aziridinyl)-phosphinyl carbamates, and aromatic nitrogen mustards.
    Lien EJ; Tong GL
    Cancer Chemother Rep; 1973; 57(3):251-61. PubMed ID: 4796118
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of new bis(1-aziridinyl) phosphinate alkylating agents containing O-phenyl N-phenylcarbamate side chains.
    Hsiao YY; Bardos TJ
    J Med Chem; 1973 Apr; 16(4):391-4. PubMed ID: 4716182
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.
    Pera PJ; Kramer DL; Sufrin JR; Porter CW
    Cancer Res; 1986 Mar; 46(3):1148-54. PubMed ID: 3080234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I and pharmacokinetic study of trans-N3P3Az2(NHMe)4.
    Mulder NH; Meijers WH; van der Meulen JD; Sleijfer DT; Uges DR; de Vries EG; Postmus PE; van de Grampel JC; Willemse PH
    Cancer Treat Rep; 1987 Feb; 71(2):155-9. PubMed ID: 3026625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased lifespan using the priming dose schedule design in carbazilquinone (NSC-134679) treatment of mouse leukemia L1210.
    Straus MJ; Goldin A
    Cancer Chemother Rep; 1972 Feb; 56(1):19-23. PubMed ID: 5030804
    [No Abstract]   [Full Text] [Related]  

  • 31. Response of human tumours 'in vitro' to CB-1954 (5-aziridinyl-2, 4-dinitrobenzamide).
    Bhat AV; Rao KV; Bapat CV
    Indian J Cancer; 1977 Jun; 14(2):132-5. PubMed ID: 914303
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
    Johnson RK; Wodinsky I; Swiniarski J; Meaney KF; Clement JJ
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1605-9. PubMed ID: 583418
    [No Abstract]   [Full Text] [Related]  

  • 33. Complete inhibition of mouse lymphoid leukemia L-1210 by carbazilquinone.
    Arakawa M
    Gan; 1972 Aug; 63(4):487-9. PubMed ID: 5081624
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone marrow toxicity of cyclophosphazenes is related to their structure and the treatment schedule.
    Mulder NH; de Vries EG; Timmer-Bosscha H; van de Grampel JC
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):195-8. PubMed ID: 3699081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-antitumor activity relationships among quinone derivatives.
    Driscoll JS; Hazard GF; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis of new nucleoside phosphoraziridines as potential site-directed antineoplastic agents.
    Breiner RG; Rose WC; Dunn JA; MacDiarmid JE; Bardos TJ
    J Med Chem; 1990 Sep; 33(9):2596-602. PubMed ID: 2391698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antitumoral action of polyamine linked cyclophosphazenes on human malignant glioma heterografts in nu/nu mice.
    Darcel F; Chatel M; Gautris P; Labarre JF
    Anticancer Res; 1990; 10(6):1563-9. PubMed ID: 2285228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of the Soviet preparations, fotrin and imifos, in erythremia].
    Petrov KIa; Buglaev AP
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):14-6. PubMed ID: 7413620
    [No Abstract]   [Full Text] [Related]  

  • 39. Alkylphosphonium salts as a new class of antitumor agents.
    Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
    Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
    Wampler GL; Kuperminc M; Regelson W
    Cancer Chemother Pharmacol; 1980; 4(1):49-52. PubMed ID: 7363402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.